Upload
gbx-summits
View
77
Download
0
Embed Size (px)
Citation preview
© Bioproduction Group | www.bio-g.com 10/24/2013
Defense in Depth
Increasing Redundancy in Biomanufacturing Facilities
October 24, 2013
Rick Johnston, Ph.D. - Principal and Founder
Gary Wright - Sr. Account Director
© Bioproduction Group | www.bio-g.com
“Defense in Depth”
• Strategy for increasing the robustness of manufacturing
systems
• Introduces redundancy in manufacturing to mitigate the
impact of failures
• Key idea: system must be tolerant to failures
• Implemented in many manufacturing environments and
high risk operational settings (such as jet-liners)
• When used successfully, avoids disruptions while
maximizing likelihood of on-time batch release
10/24/2013 1
© Bioproduction Group | www.bio-g.com
Bioproduction Group
Founded in 2007 with an exclusive focus on
Biomanufacturing Operations
Primary goal of improving Quality,
Productivity, Flexibility and Operations in
Biomanufacturing
World Class “real time” data collection,
modeling, and simulation software
Technology Assisted
Knowledge Generation Tool
Specifically designed for the unique
needs of Analysts
Improving Quality, Productivity, Flexibility
and Operations at the World’s Largest
Biomanufacturers
© Bioproduction Group | www.bio-g.com
Why “Defense in Depth”?
• Current biomanufacturing systems exhibit significant
operational variability:
– Batch-to-batch titers
– Manufacturing times
– Number of deviations per batch
• There are also still a relatively high number of
contamination events in the industry
• The industry currently “hides” these issues behind large
quantities of safety stock inventory and idled capacity
10/24/2013 3
© Bioproduction Group | www.bio-g.com
Variability is seen throughout the
manufacturing process.
10/24/2013 4
WFI Demand During Rituxan 3.5 rpw 2/09/09 to 3/30/09 (50 days) (PI Data: tank level drop plus distillate flow sums)
0
200
400
600
800
1000
1200
1400
024
48
72
96
120
145
169
193
217
241
265
289
313
337
361
385
409
434
458
482
506
530
554
578
602
626
650
674
698
723
747
771
795
819
843
867
891
915
939
963
987
1012
1036
1060
1084
1108
1132
1156
1180
LP
M
WFI consumption
(L/min)
Cadence of
batches in
production fermentor
Even run-rate cadence implies a ‘cyclic’ pattern of usage
But, pattern of consumption is NOT cyclic
© Bioproduction Group | www.bio-g.com
Temperature bands in a freezer
10/24/2013 5
Batches lost due to
temperature
malfunction
© Bioproduction Group | www.bio-g.com
Lactate levels in bioreactor: significant
batch to batch variability
10/24/2013 6
© Bioproduction Group | www.bio-g.com
Non-stationary processes (i.e. process
drift)
10/24/2013
Most modern biomanufacturing data exhibits both significant variability
and significant process drift.
CIP Times, 2002 - 2008
Ho
urs
© Bioproduction Group | www.bio-g.com
Comparative variability: semi-conductor
vs. biopharmaceuticals
Semiconductor Biopharmaceuticals
Variation in per batch
output (lower is better)
* 3% ** 30%
Number of deviations
per batch
2 80
10/24/2013 8 * Standard deviation of performance per chip, http://spectrum.ieee.org/semiconductors/design/the-threat-of-
semiconductor-variability
** Standard deviation of bulk manufacturing quantity per batch, internal Bio-G data, based on Mab production.
The data suggests that biopharmaceutical manufacturing
exhibits more significant process variability than other
industries
© Bioproduction Group | www.bio-g.com
Traditional Risk Mitigation vs. Defense
in Depth
Traditional Defense in Depth
Core Philosophy “Fixing each issue in
turn will enhance
reliability”
“Avoid inevitable
issues from affecting
reliability”
Focus Specific problem or
issue identified
Holistic view of
manufacturing process
Data Batch report or
historian data for the
issue
Entire manufacturing
system
Method Root-cause
identification and
remediation
Process as “Black
Box”
Tools Ishikawa, SPC,
regression modeling,
correlations, manual
effort
Discrete Event
Simulation, automated
analysis
10/24/2013 10 These two approaches are highly complementary
© Bioproduction Group | www.bio-g.com
“Defense in Depth”: elements of
successful risk mitigation
10/24/2013 11
Process Robustness
Scheduling Redundancy
“Surge” Capacity
Inventory Buffering
Equipment Redundancy
© Bioproduction Group | www.bio-g.com
“Defense in Depth”: How
• Bio-G has performed defense in depth analysis for more than 7 years
for leading biopharmaceutical manufacturers
• Our approach focuses on a data-driven approach to increasing
robustness (rather than a consensus driven approach, relying on
expert opinion)
• Process Robustness: identify variability in processes and improve
the systems that manage that variability. Includes items like
unplanned maintenance and process restarts.
• Scheduling Redundancy: introduce ‘holes’ in the schedule where
significant variability occurs and that variability has a large impact
• “Surge” Capacity: create the ability for parts of the facility to be able
to ‘catch up’ when delayed or recover quickly due to an outage
• Inventory Buffering: place intermediate WIP or raw materials such
that they allow optimal recovery due to a failure
10/24/2013 12
Demonstration: How we model process
robustness
• Using data from automation systems / historians
• Creating a model of the facility
• Creating an automated robustness analysis
© Bioproduction Group | www.bio-g.com
“Take home” messages
10/24/2013 14
• Increasing redundancy requires us to probe a manufacturing system,
‘imagining’ the effect of different kinds of failures
• Most of the time, failures will have little or no impact to the metrics
we care about (throughput, overtime etc.) – but the 5% of those that
do matter are critical
• An automated evaluation tool can be used to evaluate the impact of
these failures
• Single variable analysis shows us some impacts, but the best kinds
of analysis look at multiple factors at the same time (DOE approach)
• We must also look at multiple replications (i.e. repeating the same
experiment multiple times) to ensure the answers are consistent
Case Study
• From: Expanding Production at Biologics facilities: Effective strategies and Planning
Ken Hamilton, Genentech Oceanside, Biomanufacturing Conference, Boston, June
27-28 2013
© Bioproduction Group | www.bio-g.com
Installing an additional CIP skid produced the
same result as optimizing existing equipment
10/24/2013 17
Confidence Histogram - By Resource
0
5
10
15
20
25
30
3.355 3.379 3.402 3.426 3.450 3.478 3.503 3.528 3.554 3.580
Run Rate (rpw)
Nu
mb
er
of
ob
serv
ati
on
s
3 Upstream CIP Skids Upstream CIP Cycle Reductions
No difference in the run rate
and distribution of probable run
rates between case for
additional skid vs optimizing
exiting skid
© Bioproduction Group | www.bio-g.com
“ROBUSTNESS” ANALYSIS
• Examines the effect on run-rate of delays in manufacturing
operations
• Goal: to allow for a robust schedule that, despite inevitable
delays, will still allow us to reach our production targets
• Robustness analyses look at varying levels of delays, typically
from 1-8 hours (8 hours being an entire shift)
• Can also be used to analyze the ‘white space’ available for
preventative maintenance and calibration activities
• Gives engineering groups targets for further improvement and
areas to enhance operational efficiencies
Credit: Expanding Production at Biologics facilities: Effective strategies and Planning
Ken Hamilton, Genentech Oceanside, Biomanufacturing Conference, Boston, June 27-28 2013
© Bioproduction Group | www.bio-g.com Credit: Expanding Production at Biologics facilities: Effective strategies and Planning
Ken Hamilton, Genentech Oceanside, Biomanufacturing Conference, Boston, June 27-28 2013
* No manufacturing specific data shown. Graphs
show sample data only.
© Bioproduction Group | www.bio-g.com
RISKS AND “WATCH OUTS”
• Finding the optimum of likelihood of attaining target sustained
capacity increase, cost and any shutdown durations is key
– Find balance between optimizing existing equipment
versus installing back up systems
• Ensure capacity increase projects are always linked back to
business needs
– Business needs could change thru life of the project
• Ensure scope of changes is thoroughly defined at the outset
• Need to ensure operations groups and teams remain fully engaged
thru life of project
– Ideally transition project to an operations group toward
end of implementation phase
• Develop accurate cost estimates early in the project – Avoids recycle
Credit: Expanding Production at Biologics facilities: Effective strategies and Planning
Ken Hamilton, Genentech Oceanside, Biomanufacturing Conference, Boston, June 27-28 2013
© Bioproduction Group | www.bio-g.com
Key idea: do robustness analysis in
real-time and use that to schedule
10/24/2013 22
Real-time analysis and optimization is critical to
achieving ‘Best-in-Class’ performance
© Bioproduction Group | www.bio-g.com
Collect feedback on robustness from
Outlook (automated toolset)
10/24/2013 23
Allow manufacturing
to instantly react
© Bioproduction Group | www.bio-g.com
… or using smart phones that are on the
manufacturing floor
10/24/2013 24
* http://www.cocoanetics.com/2011/12/myth-busted-iphones-wont-work-with-gloves/
© Bioproduction Group | www.bio-g.com
These toolsets have a real impact on
manufacturing
10/24/2013 25
Reactionary
Expediting
86
13
Year 1 Year 2
8
86%
fewer
91%
fewer
Before
Hours Spent
(Mfg + Scheduling)
1837
1322
Year 1 Year 2
900
28%
less
51%
fewer
Before
Adherence to
Plan
76
%
88
%
Year 1 Year 2
98
%
Before
© Bioproduction Group | www.bio-g.com
Conclusions
• “Defense in Depth” is a holistic approach to designing redundancy
into manufacturing systems
• The approach requires toolsets that ‘understand’ variability and the
impact it could have
• Rather than ask for people’s view on risks, it uses a data driven
approach that is based on past performance
• Designing robust systems is a complementary approach to root
cause analysis
• These approaches do not require massive investment in
infrastructure
• When used, it can have significant benefits to the business for
metrics like reactionary expediting and performance against plan
10/24/2013 26